Drug Shortage Report for ILEVRO

Last updated on 2023-05-19 History
Report ID 189506
Drug Identification Number 02411393
Brand name ILEVRO
Common or Proper name ILEVRO 0.3%
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) NEPAFENAC
Strength(s) 0.3%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3ML
ATC code S01BC
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-04-15
Actual start date 2023-04-04
Estimated end date 2023-05-16
Actual end date 2023-05-17
Shortage status Resolved
Updated date 2023-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-05-19 French Compare
v6 2023-05-19 English Compare
v5 2023-05-08 French Compare
v4 2023-05-08 English Compare
v3 2023-04-16 English Compare
v2 2023-04-13 French Compare
v1 2023-04-13 English Compare

Showing 1 to 7 of 7